The U.S. Food and Drug Administration approved Merz’s supplemental Biologics License Application for the treatment of patients aged 2 years and older with chronic sialorrhea, or drooling.
Read More
“We designed our clinical trial program with 12 upper limb muscles to offer the most flexibility of any botulinum toxin, in order to offer patients, caregivers and doctors a safe and effective treatment option that meets the needs of pediatric patients,” says the firm’s CEO.
Read More
Merz Aesthetics global management team will now be based in Raleigh, North Carolina, centering the business in the largest and one of the fastest growing aesthetics markets in the world.
Read More
Raleigh-based Merz North America has received approval from the U.S. Food and Drug Administration to market a treatment for blepharospasm, or involuntary blinking, in adults.
Read More
Raleigh-based Merz North America, a pharmaceutical company specializing in aesthetics, skin care and neurotoxins, wants women to be guilt free about using the company’s anti-wrinkle injection, Xeomin, to smooth frown lines.
Read More
